COVID-19 rapid screening test SC-1415-20

IgGSARS-COV-2plasma

COVID-19 IgG Rapid Test Cassette (Whole Blood/Serum/Plasma) is a lateral flow immunochromatographic assay for the qualitative detection of IgG antibodies that bind to the receptor binding domain (RBD) of the SARS-Cov-2 spike (S) and / or Nucleocapsid (N) protein in whole blood, serum or plasma specimens. The COVID-19 IgG rapid test (Whole Blood/Serum/Plasma) is intended for use as an aid in the identification of individuals with an adaptive immune response to SARS-CoV-2. False positive results are possible due to cross-reactivity of pre-existing antibodies or other possible causes. Due to the risk of false positive results, confirmation of positive results by another IgG test of a different nature should be considered. The new coronavirus (SARS-CoV.2) belongs to the β genus. COVID-19 is an acute respiratory infectious disease. It mainly affects humans. Patients infected with the new coronavirus are currently the main source of infection; even asymptomatic infected individuals can be a source of infection. According to the latest epidemiological studies, the incubation period ranges from 1 to 14 days, and is mainly concentrated between the 3rd and 7th day. The most common manifestations include fever, fatigue, and dry cough. Nasal congestion, runny nose, sore throat, myalgia, and diarrhea are also present in some cases. The COVID-19 IgG Rapid Test (Whole Blood/Serum/Plasma) is a qualitative membrane-based immunoassay for the detection of SARS-CoV-2 IgG antibodies on whole blood, serum or plasma samples.The test line area is coated with anti-human IgG. During the test, the sample reacts with the antigen coated particles of the test SARS-CoV-2.